Tag: Paul M. Mansfield
-
SCD in the Era of COVID
Patients with SCD (Sickle Cell Disease) are more likely to have a severe COVID-19 disease course and a higher case-fatality rate in contrast to the general population. RBC (Red Blood Cell) transfusions are commonly given to patients with SCD and COVID-19. Hyperhemolysis syndrome (HHS) is an infrequent, severe hemolytic transfusion reaction primarily been described in…